Your browser doesn't support javascript.
loading
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program.
Conaghan, Philip G; Mysler, Eduardo; Tanaka, Yoshiya; Da Silva-Tillmann, Barbara; Shaw, Tim; Liu, John; Ferguson, Ryan; Enejosa, Jeffrey V; Cohen, Stanley; Nash, Peter; Rigby, William; Burmester, Gerd.
Affiliation
  • Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research Leeds Biomedical Research Centre, Leeds, UK. p.conaghan@leeds.ac.uk.
  • Mysler E; Organización Médica de Investigación, Buenos Aires, Argentina.
  • Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Da Silva-Tillmann B; AbbVie Inc., North Chicago, IL, USA.
  • Shaw T; AbbVie Ltd, Maidenhead, UK.
  • Liu J; AbbVie Inc., North Chicago, IL, USA.
  • Ferguson R; AbbVie Inc., North Chicago, IL, USA.
  • Enejosa JV; AbbVie Inc., North Chicago, IL, USA.
  • Cohen S; Metroplex Clinical Research Center, Dallas, TX, USA.
  • Nash P; Griffith University, Brisbane, QLD, Australia.
  • Rigby W; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
  • Burmester G; Charité-Universitätsmedizin Berlin, Berlin, Germany.
Drug Saf ; 44(5): 515-530, 2021 05.
Article in En | MEDLINE | ID: mdl-33527177
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Janus Kinase Inhibitors / Herpes Zoster Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Janus Kinase Inhibitors / Herpes Zoster Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article